[血栓后综合征 - 预防,诊断和并发症管理]
Deutsche medizinische Wochenschrift (1946)
|September 23, 2024
概括
血栓后综合征 (PTS) 是由深静脉血栓症的并发症引起的. 有效的管理涉及压缩,运动和抗凝剂,以预防和更好的结果.
科学领域:
- 血管医学 血管医学
- 血液学 血液学 血液学
- 临床治疗学 临床治疗学
背景情况:
- 血栓后综合征 (PTS) 是深静脉血栓症 (DVT) 后的一个常见并发症.
- 它是由残留的血栓负担或静脉功能障碍造成的.
- PTS显著影响患者的生活质量和医疗保健成本.
研究的目的:
- 为了阐明血栓后综合征的病理生理学.
- 突出PTS分类对于量身定制的治疗策略的重要性.
- 强调PTS预防和管理的关键干预措施.
主要方法:
- 对DVT和PTS的当前文献的综述.
- 分析导致PTS发展的因素.
- 综合有关治疗和预防措施的证据.
主要成果:
- 残留性血栓和静脉损伤是PTS的主要原因.
- 基于PTS类型的个性化治疗方法至关重要.
- 早期的压缩,体力活动和抗凝剂是至关重要的.
结论:
- 了解PTS亚型可以实现个性化的治疗和预防策略.
- 快速实施压缩,运动和抗凝剂可以改善PTS结果.
- 综合管理是缓解DVT长期影响的关键.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
Clot Retraction and Fibrinolysis
4.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
496
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
496
Disorders of Hemostasis
739
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
739
Coagulation
5.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.5K
Esophageal Varices-II: Clinical Features and Management
50
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
50


